Wealth Watch Advisors’s ResMed RMD Stock Holding History

Wealth Watch Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-18	Closed	-$4.34K	–	708
2025 Q4	$4.34K	Buy	18 +2	+13%	+$511	﹤0.01%	539
2025 Q3	$4.38K	Buy	+16	New	+$4.37K	﹤0.01%	527

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wealth Watch Advisors's RMD Position: Q1 2026 in Review

Wealth Watch Advisors sold out of ResMed (RMD) in Q1 2026, closing a stake of 18 shares — an estimated $4.34K sold.

Wealth Watch Advisors first reported a position in RMD in Q3 2025 and held it in 2 quarters. The position peaked at $4.38K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Wealth Watch Advisors reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Wealth Watch Advisors sold 18 ResMed shares in Q1 2026, an estimated $4.34K.
Wealth Watch Advisors first reported a position in ResMed in Q3 2025 and held it in 2 quarters.
Wealth Watch Advisors's ResMed position peaked at $4.38K in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Wealth Watch Advisors's 13F filing for Q1 2026, filed 15 May 2026.